Transcanna Holdings Inc (TCAN.CX)
0.01
0.00 (0.00%)
CAD |
CNSX |
May 03, 16:00
Transcanna Holdings Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| August 31, 2022 | 12.73 |
| May 31, 2022 | 7.435 |
| February 28, 2022 | 10.94 |
| November 30, 2021 | 5.506 |
| August 31, 2021 | 1.580 |
| May 31, 2021 | 1.629 |
| Date | Value |
|---|---|
| February 28, 2021 | 1.634 |
| November 30, 2020 | 1.347 |
| August 31, 2020 | 0.8599 |
| May 31, 2020 | 0.718 |
| February 29, 2020 | 0.7429 |
| November 30, 2019 | 0.8192 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.718
Minimum
May 2020
12.73
Maximum
Aug 2022
3.828
Average
1.605
Median
Debt to Equity Ratio Benchmarks
| Biocure Technology Inc | -- |
| Core One Labs Inc | 0.0443 |
| Nova Mentis Life Science Corp | 0.00 |
| Nanosphere Health Sciences Inc | -- |
| Lobe Sciences Ltd | -0.5227 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 32.51M |
| Total Liabilities (Quarterly) | 30.44M |
| Shareholders Equity (Quarterly) | 2.062M |